跳至主要内容
临床试验/NCT03800446
NCT03800446撤回不适用

Validation of a Point-of-care Device Measuring Ferritin With Capillary Blood

McMaster University0 个研究点开始时间: 2019年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
主要终点
Point of care ferritin detection accuracy

研究概览

简要总结

Measurement of iron is important for identifying both low and high iron levels in the body. Measuring a protein in the blood called ferritin is currently the easiest way to determine a patient's iron status. However, the test requires a blood sample that is be sent to the laboratory for measurement, which can cause delays in obtaining the result. The investigators are testing whether a point of care device that measures ferritin levels using a capillary blood sample is accurate compared to current methods of testing. This could allow measurement of ferritin immediately in the clinic with only a drop of blood, and enable treatment decisions based on these results.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •able to read and understand English (the consent form is in English)
  • •attending ambulatory hematology clinic and/or outpatient medical care

排除标准

  • 未提供

研究组 & 干预措施

Intervention

Other

All patients will undergo testing with the study intervention (point of care) and routine testing with serum ferritin (venous blood sample).

干预措施: Point of care ferritin test (Diagnostic Test)

结局指标

主要结局

Point of care ferritin detection accuracy

时间窗: Within 12 hours of standard testing

The proportion of subjects where the difference between the two different methods is less than 15; this will be measured by calculating the difference between the two results. The proportion for the absolute difference between the two measurement methods on the same subject that is less than 15 ng/mL will be calculated. Non-inferiority test for one proportion will be performed to examine, if, the proportion is greater than 95%, where the test p value and the one-sided 97.5% confidence interval will be reported. An interim analysis will be performed after the first 50 subjects are enrolled to test the assumptions made.

次要结局

  • Diagnostic accuracy of the new measurement method(Within 12 hours of standard testing)
  • Distribution of the differences between ferritin level as measured by the standard test and POC test(Within 12 hours of standard testing)
  • Comparison of the differences between ferritin levels as measured by the standard test and POC test in a Repeated Measures Design(Within 12 hours of standard testing)
  • Agreement between testing methods in patients who have been assessed at least twice(Within 12 hours of standard testing)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michelle Zeller

Assistant Professor; Department of Medicine, Director Operations; Hamilton Regional Laboratory Medicine Program

McMaster University

相似试验